Skip to content

Clinical Investigation of uCT 550 Deep Recon

Clinical Investigation of uCT 550 Deep Recon

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081050
Enrollment
Unknown
Registered
2024-02-21
Start date
2024-02-26
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Head and Neck:Head and neck CT examination will be performed and both FBP and Deep Recon will be used to reconstruct images.
Chest:Chest CT examination will be performed and both FBP and Deep Recon will be used to reconstruct images.
Abdomen:Abdomen contrast-enhanced CT examination will be performed and both FBP and Deep Recon will be used to reconstruct images.

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Subject Inclusion Criteria (must be met at the same time): 1. Age 18 to 75; 2. If you are a woman, you must not be pregnant or breastfeeding; 3. Those who agree to participate in this clinical trial and sign the informed consent form of the subject; 4. Those who have full capacity for civil conduct.

Exclusion criteria

Exclusion criteria: Subject exclusion criteria (any of the following are excluded): 1. Persons who do not have full capacity for civil conduct; 2. Pregnant and lactating females (if the subject is a woman of appropriate age and cannot confirm whether she is pregnant, the urine pregnancy test result will be provided); 3. Those who have the intention to have children in the next 6 months; 4. High-risk groups with contraindications to iodine contrast media and allergies (only enhanced scan needs to be excluded); 5. Persons who have received any contrast medium within 24 hours before the test (only contrast-enhanced scan needs to be excluded); 6. Patients with renal insufficiency (only enhanced scan needs to be excluded); 7. The investigator believes that it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Subjective image quality evaluation based on diagnostic requirements;

Secondary

MeasureTime frame
Image quality evaluation based on image noise level;Signal-Noise Ratio (SNR);Contrast-Noise Ratio (CNR);Safety evaluation (whether adverse events occur);

Countries

China

Contacts

Public ContactMengsu Zeng

Zhongshan Hospital Affiliated to Fudan University

zeng.mengsu@zs-hospital.sh.cn+86 21610773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026